RPL23

Large ribosomal subunit protein uL14 · P62829 · RPL23 on Sugi Atlas →

0 patent compounds predicted against RPL23, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPL23 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors PHASE2RECRUITING
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer PHASE1/PHASE2COMPLETED
Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection PHASE2COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma PHASE1COMPLETED
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
The PREServation of MUScle Function in Critically Ill Patients (PRESMUS) nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection nanUNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Quantification of GADD34 Expression in RA nanCOMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a RPL23 binder may also engage these)

ProteinNameSimilarity
Q3T057 1.000 Q3T057 →
Q90YU5 1.000 Q90YU5 →
P62832 1.000 P62832 →
P62830 1.000 P62830 →
P62831 1.000 P62831 →
G1T6D1 1.000 G1T6D1 →
Q07760 1.000 Q07760 →
Q6PC14 1.000 Q6PC14 →
P49690 0.999 P49690 →
Q5REU2 0.997 Q5REU2 →
Q9XSU3 0.991 Q9XSU3 →
Q9GNE2 0.983 Q9GNE2 →
Q9XEK8 0.978 Q9XEK8 →
P48159 0.976 P48159 →
P0CT61 0.963 P0CT61 →
P0CT60 0.960 P0CT60 →
Q1JQ99 0.957 Q1JQ99 →
A0A1D8PPT5 0.955 A0A1D8PPT5 →
P48158 0.955 P48158 →
P0CX42 0.955 P0CX42 →
RPL11 Large ribosomal subunit protein uL5 0.953 landscape →
Q3T087 0.953 Q3T087 →
P0CX41 0.951 P0CX41 →
Q6P1L8 0.951 Q6P1L8 →
G1TUB8 0.949 G1TUB8 →
P62914 0.949 P62914 →
Q9CXW4 0.949 Q9CXW4 →
Q6QMZ8 0.948 Q6QMZ8 →
Q93140 0.948 Q93140 →
Q29205 0.948 Q29205 →